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Abstract
Background: Several studies demonstrated an association of homocysteine plasma levels and the plasma
lipoprotein profile. This cross-sectional pilot study aimed at analyzing whether blood levels of the two important
cofactors of homocysteine metabolism, folate and vitamin B12, coincide with the lipoprotein profile.
Methods: In a retrospective single center approach, we analyzed the laboratory database (2003-2006) of the
University Hospital Bonn, Germany, including 1743 individuals, in whom vitamin B12, folate and at least one
lipoprotein parameter had been determined by linear multilogistic regression.
Results: Higher folate serum levels were associated with lower serum levels of low density lipoprotein cholesterol
(LDL-C; Beta = -0.164; p < 0.001), higher levels of high density lipoprotein cholesterol (HDL-C; Beta = 0.094;
p = 0.021 for trend) and a lower LDL-C-C/HDL-C-ratio (Beta = -0.210; p < 0.001). Using ANOVA, we additionally
compared the individuals of the highest with those of the lowest quartile of folate. Individuals of the highest folate
quartile had higher levels of HDL-C (1.42 ± 0.44 mmol/l vs. 1.26 ± 0.47 mmol/l; p = 0.005), lower levels of LDL-C
(3.21 ± 1.04 mmol/l vs. 3.67 ± 1.10 mmol/l; p = 0.001) and a lower LDL-C/HDL-C- ratio (2.47 ± 1.18 vs. 3.77 ± 5.29;
p = 0.002). Vitamin B12 was not associated with the lipoprotein profile.
Conclusion: In our study sample, high folate levels were associated with a favorable lipoprotein profile. A
reconfirmation of these results in a different study population with a well defined status of health, diet and
medication is warranted.
Background
Increased homocysteine (Hcys) levels and altered plasma
lipid levels are generally considered to be independent
risk factors for the development of cardiovascular dis-
ease (CVD). However, lifestyle and nutrition may cause
a coincidence of the homocysteine and lipoprotein sta-
tus. Although of potential clinical and scientific rele-
vance such a relationship is not generally acknowledged.
Recent studies have already described an inverse rela-
tionship between folate and high-density lipoprotein
cholesterol (HDL-C) levels and low folate levels have
therefore been suggested to be a cardiovascular risk fac-
tor and that the subjects with lower folate levels should
be recommended for dietary folic acid supplementation
to HDL-C levels [1,2].
Several studies have proposed a direct biochemical
link between the lipoprotein and homocysteine metabo-
lism. In rats with experimentally induced hyperhomo-
cysteinemia, plasma cholesterol levels increase, probably
because of increased expression and activity of hepatic
HMG-CoA reductase, a rate-limiting enzyme in choles-
terol biosynthesis [3-5]. Homocysteine supplementation
leads to an inhibition of phospholipid methylation and
triacylglycerol accumulation in yeast [6], and diet-
induced hyperhomocysteinemia leads to cholesterol and
triacylglycerol accumulation in mouse liver [7]. The
nutritional intake of folate and, to a lower extent, of
vitamin B12 are major determinants of plasma homocys-
teine levels [8]. In wildtype and APOE-deficient mice, * Correspondence: michael.linnebank@usz.ch
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serum and liver cholesterol and to an altered expression
profile of the cholesterol biosynthesis pathway [9].
This study aimed at testing the correlation of plasma
levels of vitamin B12 and folate and lipoproteins in a
large sample.
Methods
In a retrospective mono-centered approach, we analyzed
the routine laboratory database (2003-2006) of the Uni-
versity Hospital Bonn, Germany using data that were
made anonymous. We selected all in- and outpatients in
whom vitamin B12 and folate as well as lipoproteins
had been determined (table). Serum triglycerides (TG),
total cholesterol (TC), high density lipoprotein choles-
terol (HDL) and low density lipoprotein cholesterol
(LDL-C) were measured on the Dimension RxL clinical
chemistry system (Dade Behring, Schwalbach, Germany)
with enzymatic methods using the manufacturer’s
reagents and instructions.
Hcys was determined by means of fully automated
particle-enhanced immunonephelometry with a BN II
System (Dade Behring). Bound homocysteine in the
heparinized plasma sample is reduced to free homocys-
teine by the action of dithiothreitol, and then converted
enzmatically to S-adenosyl-homocysteine (SAH) in the
next step. Conjugated S-adenosyl-cysteine (SAC), added
at the onset of the reaction, competes with SAH in the
sample for bonding by anti-SAH antibodies bound to
polystyrene particles. The result is evaluated by compar-
ison with a standard of known concentration.
Serum concentrations of vitamin B12 and folate were
measured by means of a competitive chemiluminescent
immunoassay with an Accessâ„¢ Immunoassy System
(Beckman Coulter, Krefeld, Germany) according to the
manufacturer’s instructions.
Due to anonymous data extraction, information on
diagnosis and diet were not available.
Because some parameters were not normally distribu-
ted, log transformation was performed for statistical ana-
lysis. Multiple linear regression analysis with a =0 . 0 1
(multiple testing of four different lipoproteins) was used
to simultaneously analyze independent associations of
age, gender, folate and vitamin B12 on the lipoprotein
levels as dependent variables. We used stepping mode
criteria with a probability of 0.05 for entry and of 0.10 for
removal from the equation. Due to the low number of
patients for whom homocysteine was known, homocys-
teine was not included as covariable in the multivariate
model. Instead, bivariate Pearson’sa n a l y s i sw a sc a l c u -
lated. The lipoproteins values of folate and vitamin B12
quartiles were compared by ANOVA. Since this analysis
was done following the results of the regression analysis,
we did not correct for multiple testing (a = 0.05).
Results
1743 individuals were included of whom age (mean
age ± standard deviation: 46 ± 17), gender (45% female),
plasma folate levels and plasma vitamin B12 levels were
known. The number of available values differed between
the lipoprotein parameters (table 1). As shown in
table 2, higher folate levels were associated with lower
levels of LDL-C, a lower LDL-C/HDL-C-ratio, and, for
trend, higher HDL-C levels. Folate was associated with
vitamin B12 (Beta = 0.223; p < 0.001). However, vitamin
B12 was not associated with the lipoprotein profile.
Using ANOVA, we additionally compared the indivi-
duals of the highest with those of the lowest quartile of
folate and vitamin B12 levels and found that individuals
in the highest folate quartile had a 1.53-fold lower LDL-
C / H D L - C - r a t i oi nc o m p a r i s o nt ot h o s ei nt h el o w e s t
folate quartile (table 3), whereas quartiles of vitamin
B12 levels showed no significant association with lipo-
protein levels.
Linear logistic regression analysis (table 2) revealed
that male gender was associated with higher levels of
triglycerides, lower levels of HDL-C, and a higher LDL-
C/HDL-C ratio. In bivariate Pearson’sa n a l y s i s ,h o m o -
cysteine correlated with folate (Pearson = -0.408, p <
0.001) and vitamin B12 (Pearson = -0.0228, p = 0.011),
but not with lipoprotein parameters. However, respec-
tive data were only available for n = 63 (homocysteine
and triglycerides) and n = 123 (homocysteine and cho-
lesterol; details not shown) patients. Higher age was
associated with higher levels triglycerides, higher levels
of LDL-C, a higher LDL-C/HDL-C ratio (table 2).
Discussion
In a retrospective database analysis we confirmed that
male gender and older age were associated with more
unfavorable lipoprotein profiles. More important, we
also observed that higher levels of folate were associated
with a favorable lipoprotein profile independently of the
covariables age and gender. Vitamin B12 levels did not
influence the lipoprotein profile in our study sample. As
limitation, our study made use of an unselected mono-
centered anonymous patient sample that cannot be
representative for any general population. The available
set of lipoprotein parameters differed between the
enrolled samples and the results cannot be controlled
for any influence of drugs, diseases, physical exercise,
and diet or body mass index. Thus, the significance and
the effect size of folate levels for the lipoprotein profile
should additionally be analyzed in samples of individuals
of defined clinical and dietary status as our data raise
the question whether high folate levels and favorable
lipoprotein profiles coincide due to nutritional reasons
or a “healthy lifestyle”. However, the association between
the folate and the plasma lipoprotein profile observed in
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a relevant confounder for effects of folate or lipids,
respectively, on vascular disease. Thus, both parameters
should be analyzed in multivariate approaches in respec-
tive studies.
The differences in the levels of LDL-C, HDL-C and
LDL-C/HDL-C ratio observed in subjects with high or
low levels of folate should be physiologically relevant. In
a large prospective study including 12339 participants it
was shown that a one standard deviation (1 mmol/L)
increase in LDL above the mean of 3.50 mmol/L is asso-
ciated with an age adjusted relative risk for coronary
heart disease of 1.42 for men and 1.37 for women. A
one standard deviation increase in HDL (0.40 mmol/L)
above the mean of 1.18 mmol/L in men and 1.51 mmol/
L in women was associated with an adjusted relative risk
of 0.64 and 0.69, respectively [10]. Although the differ-
ences in HDL and LDL levels in high and low folate
quartiles where not as high as one standard deviation,
our data demonstrate that folate levels have a relevant
influence on HDL and LDL levels in addition to other
factors such as age and gender.
Additionally it is tempting to speculate about a possi-
ble direct biochemical link between the plasma lipopro-
tein and the folate metabolism. Our dataset did not
allow powerful analyses of the association of homocys-
teine with lipoprotein parameters. Therefore, it is not
possible to decide, whether the homocysteine lowering
effect of folate or a direct effect of folate is statistically
more likely to explain any association between folate
and lipid levels. Folate is transported into cells by two
distinct transport mechanisms. The first is a low affinity
system called reduced folate carrier 1 (RFC1). The sec-
ond system is a high affinity system that involves phago-
cytosis of folate by membrane bound folate receptors.
When folate levels are low, the membrane bound folate
receptors are used [11]. Previous studies showed that
cholesterol regulates the rate of cellular folate import by
facilitating the clustering of membrane bound folate
receptors on the cell membrane [12-14]. Fibroblasts
from patients that are unable to produce sufficient cho-
lesterol levels show decreased folate import [15]. Thus,
the observed association of folate plasma levels and the
Table 1 Laboratory parameters included in this study
parameter individuals analyzed mean value standard deviation median value range reference range
folate (nmol/l) 1743 14.94 8.53 12.21 2.18-44.61 6.8-39
vitamin B12
(pmol/l)
1743 215 147 255 60-1053 130-675
Homocysteine (Âµmol/l) 123 13.6 4.4 12.5 6.8-30.6 <16
LDL-C (mmol/l) 593 3.34 1.05 3.28 0.21-7.81 <4.10
HDL-C (mmol/l) 593 1.40 0.49 1.34 0.10-3.36 1.0-1.55
total cholesterol (mmol/l) 123 5.61 1.08 5.59 2.74-8.92 <6.20
triglycerides (mmol/l) 1468 1.56 1.49 1.26 0.25-30.46 <1.70
Table 2 Effect of age, gender, folate and vitamin B12 on lipoprotein levels
triglycerides HDL-C LDL-C LDL-C/HDL-C total cholesterol
n 1468 593 593 592 123
Folate Beta = -0.045; p = 0.087 Beta = 0.094; p = 0.021 Beta = -0.164; p < 0.001 Beta = -0.210; p < 0.001 Beta = -0.138; p = 0.147
Vitamin B12 Beta = -0.051; p = 0.052 Beta = 0.030 p = 0.458 Beta = 0.070; p = 0.094 Beta = 0.058; p = 0.164 Beta = -0.151; p = 0.110
Age (year) Beta = 0.125; p < 0.001 Beta = -0.012; p = 0.762 Beta = 0.254; p < 0.001 Beta = 0.160; p < 0.001 Beta = 0.178; p = 0.054
Gender (male) Beta = 0.211; p < 0.001 Beta = -0.352; p < 0.001 Beta = -0.082; p = 0.045 Beta = 0.186; p < 0.001 Beta = -0.180; p = 0.052
Linear logistic regression analysis (standardized partial regression coefficient Beta and p-value) of the independent predictive character of the covariables age,
gender, plasma folate level, and plasma vitamin B12 level for the dependent variables triglycerides, HDL-C, LDL-C, LDL-C/HDL-C-ratio and total cholesterol levels
are depicted. As these were five separate analyses, we set the level of significance to alpha = 0.01
Table 3 Laboratory parameters of individuals of the
highest and lowest quartiles of folate levels
high folate
(≥18.75 nmol/l)
low folate
(≤8.75 nmol/l)
ANOVA
vitamin B12 (pmol/l) 334 ± 154
(n = 407)
260 ± 145
(n = 416)
p < 0.001
Triglycerides (mmol/l) 1.47 ± 0.94
(n = 334)
1.66 ± 1.82
(n = 388)
p = 0.075
HDL-C (mmol/l) 1.42 ± 0.44
(n = 170)
1.26 ± 0.47
(n = 87)
p = 0.005
LDL-C (mmol/l) 3.21 ± 1.04
(n = 167)
3.67 ± 1.10
(n = 87)
p = 0.007
LDL-C/HDL-C-ratio 2.47 ± 1.18
(n = 167)
3.77 ± 5.29
(n = 87)
p < 0.001
Total cholesterol (mmol/l) 5.43 ± 0.97
(n = 36)
5.77 ± 1.18
(n = 19)
p = 0.346
Semmler et al. Nutrition Journal 2010, 9:31
http://www.nutritionj.com/content/9/1/31
Page 3 of 4lipoprotein profile may be based on both nutritional and
biochemical factors. Studies investigating whether medi-
cal manipulation of the lipoprotein profile impacts folate
metabolism and whether folate substitution is relevant
for the lipoprotein profile may be interesting.
Conclusion
A higher level of folate is associated with a favorable
lipoprotein profile independently of the important cov-
ariables age and gender. A reconfirmation of these
results in different study populations with a well defined
status of health, diet and medication may help to clarify
whether the lipoprotein and folate status coincide due
to nutritional reasons or due to a biochemical link
between folate and lipoprotein metabolism.
Acknowledgements
No acknowledgements
Author details
1University Zurich, Department of Neurology, Switzerland.
2University Bonn,
Department of Neurology, Bonn, Germany.
3University Bonn, Department of
Clinical Biochemistry and Pharmacology, Germany.
4VU University Medical
Center, Department of Internal Medicine and Metabolic Unit, Amsterdam,
The Netherlands.
Authors’ contributions
AS, SM, and ML designed the study, performed statistical analysis and wrote
the manuscript.
AG, SF, TK, BZ, and BSW collected the data, helped with data analysis and
contributed to finalisation of the manuscript. YS, and HB contributed to the
study design and manuscript preparation.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 February 2010 Accepted: 28 July 2010
Published: 28 July 2010
References
1. Imamura A, Murakami R, Takahashi R, Cheng XW, Numaguchi Y,
Murohara T, Okumura K: Low folate levels may be an atherogenic factor
regardless of homocysteine levels in young healthy nonsmokers.
Metabolism 2010, 59(5):728-733.
2. Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Ranieri M, Mele C,
Lanzone A: L-folic acid supplementation in healthy postmenopausal
women: effect on homocysteine and glycolipid metabolism. J Clin
Endocrinol Metab 2005, 90(8):4622-4629.
3. Sharma M, Rai SK, Tiwari M, Chandra R: Effect of hyperhomocysteinemia
on cardiovascular risk factors and initiation of atherosclerosis in Wistar
rats. Eur J Pharmacol 2007, 574(1):49-60.
4. Hirche F, Schroder A, Knoth B, Stangl GI, Eder K: Methionine-induced
elevation of plasma homocysteine concentration is associated with an
increase of plasma cholesterol in adult rats. Ann Nutr Metab 2006,
50(2):139-146.
5. Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, O K:
Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and
lipid accumulation via activation of transcription factors. Am J Physiol
Endocrinol Metab 2005, 288(5):E1002-1010.
6. Malanovic N, Streith I, Wolinski H, Rechberger G, Kohlwein SD, Tehlivets O:
S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation
metabolism, regulates phosphatidylcholine synthesis and triacylglycerol
homeostasis in yeast: implications for homocysteine as a risk factor of
atherosclerosis. J Biol Chem 2008, 283(35):23989-99.
7. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J,
Maeda N, Krisans SK, Malinow MR, et al: Homocysteine-induced
endoplasmic reticulum stress causes dysregulation of the cholesterol
and triglyceride biosynthetic pathways. J Clin Invest 2001,
107(10):1263-1273.
8. Finkelstein JD: Pathways and regulation of homocysteine metabolism in
mammals. Semin Thromb Hemost 2000, 26(3):219-225.
9. Kitami T, Rubio R, O’Brien W, Quackenbush J, Nadeau JH: Gene-
environment interactions reveal a homeostatic role for cholesterol
metabolism during dietary folate perturbation in mice. Physiol Genomics
2008, 35(2):182-190.
10. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D,
Patsch W: Coronary heart disease prediction from lipoprotein cholesterol
levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL
density subfractions: The Atherosclerosis Risk in Communities (ARIC)
Study. Circulation 2001, 104(10):1108-1113.
11. Mauritz R, Peters GJ, Kathmann I, Teshale H, Noordhuis P, Comijn EM,
Pinedo HM, Jansen G: Dynamics of antifolate transport via the reduced
folate carrier and the membrane folate receptor in murine leukaemia
cells in vitro and in vivo. Cancer Chemother Pharmacol 2008, 62(6):937-948.
12. Chang WJ, Rothberg KG, Kamen BA, Anderson RG: Lowering the
cholesterol content of MA104 cells inhibits receptor-mediated transport
of folate. J Cell Biol 1992, 118(1):63-69.
13. Smart EJ, Mineo C, Anderson RG: Clustered folate receptors deliver
5-methyltetrahydrofolate to cytoplasm of MA104 cells. J Cell Biol 1996,
134(5):1169-1177.
14. Rothberg KG, Ying YS, Kamen BA, Anderson RG: Cholesterol controls the
clustering of the glycophospholipid-anchored membrane receptor for
5-methyltetrahydrofolate. J Cell Biol 1990, 111(6 Pt 2):2931-2938.
15. Tulenko TN, Boeze-Battaglia K, Mason RP, Tint GS, Steiner RD, Connor WE,
Labelle EF: A membrane defect in the pathogenesis of the Smith-Lemli-
Opitz syndrome. J Lipid Res 2006, 47(1):134-143.
doi:10.1186/1475-2891-9-31
Cite this article as: Semmler et al.: Plasma folate levels are associated
with the lipoprotein profile: a retrospective database analysis. Nutrition
Journal 2010 9:31.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Semmler et al. Nutrition Journal 2010, 9:31
http://www.nutritionj.com/content/9/1/31
Page 4 of 4